AML AML AML AML AML ALL AML MPN AML

Size: px
Start display at page:

Download "AML AML AML AML AML ALL AML MPN AML"

Transcription

1 Absence of T & B cells SCID Absence of T, normal B cell SCID Acquired cytopenic syndrome Acquired immune deficiency syndrome (HIV infection) Acquired Pure Red Cell Aplasia (PRCA) Acute undifferentiated leukaemia Acute biphenotypic leukaemia Acute leukaemia, secondary to previous MDS diagnosis Acute leukaemia, secondary to previous diagnosis Acute leukaemia, secondary to treatment of primary disease Acute lymphocytic leukaemia Acute mast cell leukaemia Acute myelofibrosis (Chronic idiopathic myelofibrosis) Acute myeloid leukaemia Acute myelosclerosis (Chronic idiopathic myelofibrosis) ADA deficiency (SCID) Adenocarcinoma origin X Adenosine deaminase deficiency (SCID) (ADA) Adrenoleukodystrophy Adult T-cell lymphoma/leukaemia (HTLV1+) Aggressive NK-cell leukaemia Agranulocytosis (Kostmann) AIDS (HIV infection) AILD (Angioimmunoblastic lymphoma T-cell) Albers-Schonberg Disease (Osteopetrosis) ALS (Amyotrophic lateral sclerosis) Amegakaryocytosis acquired Amegakaryocytosis (congenital) Amyloidosis Amyotrophic lateral sclerosis Anaplastic large-cell, T/null cell types Anaplastic large-cell, T/null cell, primary cutaneous lymphoma Anaplastic large-cell, T/null cell, primary systemic lymphoma Angioimmunoblastic lymphoma T-cell (AILD) Angiosarcoma Antiphospholipid syndrome Aplastic anaemia Aspartyl glucosaminuria Astrocytoma Ataxia telangiectasia Atypic Hairy Cell Leukaemia Atypical s Autoimmune lymphoproliferative syndrome Bare lymphocyte/lack of HLA- antig xp Batten disease (Neuronal ceriod lipofuscinosis) B-Cell Lymphocytic Leukaemia B-cell lymphomas (NHL), unspecified Behçet s syndrome Berlin breakage syndrome B-glucuronidase deficiency (VII) Blast NK cell Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) Bone sarcoma (exclude Ewing sarcoma, include PNET sarcoma) BM failure-saa BM failure-saa BM failure-other BM failure-saa Lymphoblastic Lymphoma

2 BPDCN Breast Cancer (Inflammatory / Non inflammatory) Burkitt cell leukemia Burkitt s lymphoma Cartilage hair hypoplasia Castleman's disease Diagnosis CD40 ligand deficiency Central nervous system (include CNS PNET) Chediak-Higashi syndrome Choriocarcinoma Chronic eosinophylic leukaemia Chronic granulomatous disease Chronic inflammatory demyelinating polyneuropathy Chronic myelomonocytic leukaemia Chronic Active Epstein-barr Virus infection (CAEBV) Chronic idiopathic myelofibrosis Chronic lymphocytic leukaemia Chronic myeloid leukaemia Chronic myeloid leukaemia, atypical Churg-Strauss CID CID with Ig CID with Immunoglobulins (CID with Ig) CIDP (Chronic inflammatory demyelinating polyneuropathy) CLL CLL/SLL, atypical CMML (Chronic myelomonocytic leukaemia) CMMoL (Chronic myelomonocytic leukaemia) CNS tumours Colon adenocarcinoma Combined myelodysplastic & myeloproliferative neoplasm Combined myelodysplastic & myeloproliferative syndromes Combined immune deficiency Common variable immunodeficiency (CID) Congenital neutropaenia (Kostmann syndrome) Congenital amegakaryocytosis Congenital PRCA Crohn s disease Crow-Fukase syndrome (POEMS) Cytopaenia Dermatomyositis Di George anomaly Diamond-Blackfan anaemia Diffuse large B-cell lymphoma Drepanocytosis Duncan syndrome (X-linked lymphoproliferative syndrome) Dyserythropoietic anaemia Dyskeratosis congenita EBV related lymphohistiocytosis (HLH) Embryonal carcinoma Enteropathy-type T-cell lymphoma Ependymoma Erythrophagocytic lympohystiocytosis/hemoph agocytosis Breast cancer Other LPD Hemoglobinopathy-other

3 Evan syndrome Ewing sarcoma Extranodal marginal zone of MALT type lymphoma Extranodal NK/T-cell lymphoma, nasal type Familial erythro/hemophagocytic lymphohistiocytosis (FELH) Familial reticuloendotheliosis (Omenn's syndrome) Fanconi anaemia FELH / FLH (Familial erythro / hemophagocytic lymphohistiocytosis) FHLH (Familial hemophagocytic lymphohistiocytosis) Fibrosarcoma Follicular lymphoma Follicular dendritic sarcoma Fucosidosis Gastric carcinoma + adenocarcinoma Gaucher disease Genetic agranulocytosis (Kostmann syndrome) Germ cell tumour Giant cell arteritis Glanzmann thrombasthenia Glioblastoma Globoid leukodystrophy (Krabbe disease) Glucose storage disease Granulocytic sarcoma Grave's disease Griscelli syndrome Haemoglobinopathy, heterozygous Hairy cell leukaemia Hairy Cell Leukaemia, atypic Hemangiosarcoma Hemolytic anemia, acquired Hemolytic anemia, congenital Hemolytic anemia, not congenital Hemophagocytosis (reactive or viral associated) Hepatosplenic gamma-delta T-cell lymphoma HGPRT deficiency (Lesch- Nyhan) Histiocytic sarcoma Histiocytosis X (Langerhans Cell Histiocytosis) HIV infection Hodgkin's Lymphoma Hunter syndrome (II) Hurler / Scheie syndrome Hurler syndrome (I) Hydroa Vacciniforme Hyper eosinophilic syndrome Hyper IgM syndrome (CD40 ligand deficiency) I-cell disease Idiopathic thrombocytopenic purpura (ITP) IL-7R alpha deficiency Immune deficiencies (primary) Immune deficiency with increased IgM (CD40 ligand deficiency) Inborn errors (except congenital BMF) Inborn errors of metabolism Inflammatory breast cancer Interferon gamma receptor deficiency ITP (Idiopathic thrombocytopenic purpura) JAK3 deficiency J (Juvenile myelomonocytic leukaemia) Ewing Germ cell tumor Others Hemoglobinopathy-other BM failure-other Langerhans cell histiocytosis Hodgkin Lymphoma Others Breast cancer

4 JCMML (Juvenile myelomonocytic leukaemia) JIA (Juvenile idiopathic arthritis) JMML (Juvenile myelomonocytic leukaemia) Juvenile myelomonocytic leukaemia Juvenile idiopathic arthritis (JIA) Kahler disease Kidney tumour (non Wilms) Kostmann syndrome Krabbe disease (globoid leukodystrophy) LAD (Leukocyte adhesion deficiency) Langerhans Cell Histiocytosis (Histiocytosis-X) Leiomyosarcoma Lennert lymphoma Lesch-Nyhan (HGPRT deficiency) Leukocyte adhesion deficiency (LAD) LFA deficiency (Leukocyte adhesion deficiency) Liposarcoma Louis-Bar Syndrome (Ataxia telangiectasia) Lung cancer, non-small cell Lung cancer, small cell Lymphoplasmacytic lymphoma Malignant histiocytosis MALT (Extranodal marginal zone of MALT type lymphoma) Mannosidosis Mantle cell lymphoma Marchiafava-Micheli syndrome Maroteaux-Lamy (VI) Mastocytosis, systemic MDS Mediastinal neoplasm Medulloblastoma Melanoma Metachromatic leukodystrophy MHC class II-deficiency Mixed tumour with seminoma Mixed tumour without seminoma Morquio (IV) MPS (not Mucopolysaccharidosis) MS (Multiple Sclerosis) Mucolipidoses Mucolipidoses II Mucopolysaccharidosis Multiple myeloma Multiple Sclerosis (MS) Myasthenia gravis Mycosis fungoides Myelodysplastic syndrome Myelodysplastic & myeloproliferative neoplasm combined Myelodysplastic & myeloproliferative syndromes combined Myelofibrosis with myeloid metaplasia (Chronic idiopathic myelofibrosis) Myeloproliferative neoplasm Myeloproliferative syndrome Myelosclerosis (Chronic idiopathic myelofibrosis) Necrotising arteritis Neuroblastoma Neurogenic sarcoma Neuronal ceriod lipofuscinosis (Batten disease) Langerhans cell histiocytosis Others Neuroblastoma

5 Neutrophil actin deficiency Nezelof syndrome (CID with Ig) NHL (Non Hodgkins Lymphoma) Niemann-Pick disease Nijmegen syndrome Nodal marginal zone B-cell lymphoma Non Hodgkins Lymphoma, unspecified Non inflammatory breast cancer Non-small cell lung cancer NSCLC Oligodendroglioma Omenn's syndrome Osteopetrosis Osteosarcoma Other (non Wilms) kidney tumour Other gliomas Ovarian adenocarcinoma Overlapping necrotising arteritis Paroxysmal nocturnal hemoglobinuria () PEP syndrome (POEMS) Peripheral T-cell Plasma cell disorders Plasma cell leukemia Platelet defect, congenital PLL PNET PNP- SCID POEMS syndrome Polyarteritis nodosa Polycythemia vera Polymyositis Polysaccharide hydrolase abnormalities Post-transplant lymphoproliferative disease PRCA (acquired) PRCA (congenital) PRCA (not congenital) Precursor B-lymphoblastic leukemia/lymphoma Precursor T-lymphoblastic lymphoma/leukemia Primary amyloidosis Prolymphocytic Leukaemia Prolymphocytic Leukaemia B- cell Prolymphocytic Leukaemia T- cell Psoriatic arthritis/psoriasis PTLD Pure red cell, acquired Pure white cell, acquired Purine nucleoside phosphorylase deficiency (SCID) (PNP-) Purtilo (X-linked lymphoproliferative syndrome) PWC (acquired) PWC (genetic) Pyruvate kinase deficiency resulting in hemolytic anaemia, congenital Rag-1 or Rag-2 Refractory anaemia (RA) Reticular dysgenesis (SCID) Retinoblastoma Rhabdomyosarcoma Rheumatoid arthritis Breast cancer Other LPD Aquired pure red cell anemia Aquired pure red cell anemia Lymphoblastic Lymphoma Lymphoblastic Lymphoma Other LPD Aquired pure red cell anemia BM failure-other

6 Richter Sanfilippo (III) Sarcoma not otherwise specified Sarcoma PNET Scheie syndrome (IS) SCID SCLC Scleroderma (Systemic sclerosis) Diagnosis Secondary acute leukaemia after MDS Secondary acute leukaemia after MPS Secondary acute leukaemia, after treatment of primary disease Seemanova syndrome Seminoma Severe combined immune deficiency (SCID) Severe congenital neutropenia (SCN) Severe mosquito bite allergy Sezary syndrome Shwachman-Diamond Sickle cell disease Sjögren syndrome SLE (Systemic lupus erythematosus) SLL Small cell lung cancer Small lymphocytic lymphoma Soft tissue sarcoma (include PNET sarcoma) Solid tumour Solitary plasmacytoma Sphingolipidoses Splenic marginal zone B-cell lymphoma Stills disease Subcutaneous panniculitis- like T-cell lymphoma Synovial sarcoma Systemic mastocytosis Systemic lupus erythematosus (SLE) Systemic sclerosis Takatsuki disease (POEMS) Takayasu T-cell granular lymphocytic leukaemia T-cell lymphomas (NHL), unspecified Teratocarcinoma Thalassemia Thrombocythemia (essential / primary) Thymoma T-lymphocyte deficiency (CID with Ig) Ulcerative colitis Undifferentiated carcinoma Waldenstrom Wegener granulomatosis Wilm tumour Wiskott Aldrich syndrome (XL) Wolman disease X-linked lymphoproliferative syndrome XLP (X-linked lymphoproliferative syndrome) Yolk sac tumour Hemoglobinopathy-other Hemoglobinopathy-Thalassemia

Cord blood Banking Transplant List for One USA Bank - StemCyte www.stemcyte.com/cordblood-banking-transplant-list

Cord blood Banking Transplant List for One USA Bank - StemCyte www.stemcyte.com/cordblood-banking-transplant-list Cells4Life is the oldest and largest cord blood storage company in the UK. We are governed by some of the world's most stringent medical laws, and are currently the only stem cell storage company in the

More information

Diseases Treated by Blood Stem Cells

Diseases Treated by Blood Stem Cells Diseases Treated by Blood Stem Cells This is the only website to group hematopoietic (blood) stem cell treatments according to whether they are standard, in trial, or experimental. (Courtesy of Parents

More information

www.assureimmune.com

www.assureimmune.com Stem Cell Bank Cord Blood Important facts for when you re expecting www.assureimmune.com Banking your baby s umbilical cord blood could be a potentially lifesaving decision. There s a brief moment of opportunity

More information

INFORMATION KIT. americordblood.com 866.503.6005

INFORMATION KIT. americordblood.com 866.503.6005 INFORMATION KIT americordblood.com 866.503.6005 QUALITY INNOVATION VALUE AMERICORD S FULL SUITE OF STEM CELL BANKING PRODUCTS CORD BLOOD 2.0 CORD TISSUE BANKING PLACENTA TISSUE BANKING Preserve up to two

More information

Saving lives globally through mutual miracles. LifeCord is a public non-profit cord blood bank licensed by the FDA.

Saving lives globally through mutual miracles. LifeCord is a public non-profit cord blood bank licensed by the FDA. Saving lives globally through mutual miracles LifeCord is a public non-profit cord blood bank licensed by the FDA. Donating your baby s cord to a public cord blood bank can save lives globally. You can

More information

dedicated umbilical cord cryopreservation

dedicated umbilical cord cryopreservation cell factory dedicated umbilical cord cryopreservation Cell Factory Bioscience Institute is a cell factory dedicated to biological cryopreservation, cellular culture and scientific research. The Bioscience

More information

Non-Hodgkin s Lymphoma

Non-Hodgkin s Lymphoma Non-Hodgkin s Lymphoma Luis Fayad, MD Assistant Professor Clinical Medical Director Lymphoma/Myeloma Department Non-Hodgkin s Lymphoma Non-Hodgkin s lymphomas (NHL) are a heterogeneous group of malignant

More information

Cord Cor Blood Banking Scott N. Furlan, MD Ellen S. Plummer, Plummer MD

Cord Cor Blood Banking Scott N. Furlan, MD Ellen S. Plummer, Plummer MD Cord Blood Banking Scott N. Furlan, MD Ellen S.Plummer, MD Overview Background Biology of Stem Cell Transplant Opportunities i at Parkland Logistics of Banking Potential Barriers Indications for HCT Cancer

More information

www.lifesouthcord.org

www.lifesouthcord.org www.lifesouthcord.org www.lifesouth.org (888) 795-2707 LifeCord Gainesville, FL www.lifesouthcord.org John Wingard. M.D. LifeCord Medical Director Price Eminent Scholar and Professor of Medicine Deputy

More information

NOW OFFERING. FamilyCord.com

NOW OFFERING. FamilyCord.com Experience a lifetime of security NOW OFFERING FamilyCord.com Dear Expectant Parent, Congratulations on the upcoming birth of your baby. As a physician and father, I know how important it is to protect

More information

Collaboration to collect Autologous transplant outcomes in Lymphoma and Myeloma (CALM) Additional Questionnaire (MED C) INCLUSION CRITERIA CALM STUDY

Collaboration to collect Autologous transplant outcomes in Lymphoma and Myeloma (CALM) Additional Questionnaire (MED C) INCLUSION CRITERIA CALM STUDY Additional Questionnaire (MED C) CALM study Inclusion period: 01/01/2008 to 31/12/2011 PATIENT REGISTRATION FORM Disease Diagnosis Lymphoma S Non Hodgkin Lymphoma (NHL) Mature B-cell neoplasm Follicular

More information

PROTECT. Insurance - Terms & Conditions

PROTECT. Insurance - Terms & Conditions PROTECT Insurance - Terms & Conditions FutureLife Medical Expenses Insurance TABLE OF BENEFITS The table below details the monetary limits and benefits for each Insured Person selected by the Member and

More information

Chapter 4 Section 23.1. High Dose Chemotherapy (HDC) And Stem Cell Transplantation

Chapter 4 Section 23.1. High Dose Chemotherapy (HDC) And Stem Cell Transplantation Surgery Chapter 4 Section 23.1 High Dose Chemotherapy (HDC) And Stem Cell Transplantation Issue Date: November 1, 1983 Authority: 32 CFR 199.4(e)(5) and (g)(15) 1.0 CPT 1 PROCEDURE CODES 38205, 38207,

More information

Oncology Best Practice Documentation

Oncology Best Practice Documentation Oncology Best Practice Documentation Click on the desired Diagnoses link or press Enter to view all information. Diagnoses: Solid Tumors Lymphomas Leukemias Myelodysplastic Syndrome Pathology Findings

More information

STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA

STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA STEM CELLS : A THERAPEUTIC REVOLUTION JACQUES KADOCH ROBERT HEMMINGS MARINELA MANDRA OVO CLINIC I 8000 BLVD DECARIE, MONTREAL QC H4P 2S4 I 514.798.2000 I OVOCLINIC.COM 2 a therapeutic revolution As the

More information

Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation. April 2013. Reference: NHSCB/B04/P/a

Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation. April 2013. Reference: NHSCB/B04/P/a Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation April 2013 Reference: NHS Commissioning Board Clinical Commissioning Policy: Haematopoietic Stem Cell Transplantation First published:

More information

Co-pay assistance organizations offering assistance

Co-pay assistance organizations offering assistance Acromegaly Acute Exacerbations of Multiple Sclerosis Acute Porphyrias Advanced Idiopathic Parkinson' s Disease Age-Related Macular Degeneration www.theassistancefund.org Alcohol Dependence Alpha-1 Antitrypsin

More information

LCD for Erythrocyte Sedimentation Rate (ESR)

LCD for Erythrocyte Sedimentation Rate (ESR) LCD for Erythrocyte Sedimentation Rate (ESR) Applicable CPT Code(s): 85651 Sedimentation Rate, Erythrocyte; Non-Automated 85652 Sedimentation Rate, Erythrocyte; Automated ICD-9 Codes that Support Medical

More information

Stem cell research and therapy: an overview

Stem cell research and therapy: an overview Stem cell research and therapy: an overview Michael S. Pepper MBChB, PhD, MD 1 Institute for Cellular and Molecular Medicine Overview Stem cell principles Therapeutic applications Stem cell legislation

More information

Cord blood banking. Make it part of your family s plan.

Cord blood banking. Make it part of your family s plan. Cord blood banking. Make it part of your family s plan. ViaCord.Empowering healing for generations to come. If you re thinking about saving your baby s cord blood, you probably have plenty of questions.

More information

Newborn Stem Cell Banking - Free Information Kit. 866.396.7283 www.alphacord.com

Newborn Stem Cell Banking - Free Information Kit. 866.396.7283 www.alphacord.com Newborn Stem Cell Banking - Free Information Kit www.alphacord.com Thank You For Your Interest This free information kit provides you with everything you need to know to store your Newborn s stem cells

More information

Lymphoma Diagnosis and Classification

Lymphoma Diagnosis and Classification Lymphoma Diagnosis and Classification By Atef Shrit, MD, Pathology B- and T/NK-cell lymphomas are clonal neoplasms of immature and mature B-lymphocytes, T-lymphocytes or natural killer cells at various

More information

MALIGNANT LYMPHOMAS. Dr. Olga Vujovic (Updated August 2010)

MALIGNANT LYMPHOMAS. Dr. Olga Vujovic (Updated August 2010) MALIGNANT LYMPHOMAS Dr. Olga Vujovic (Updated August 2010) Malignant lymphomas consist of Hodgkin and non-hodgkin lymphomas. The current management of these diseases involves a multi-disciplinary approach.

More information

Stem Cell Transplantation and the Canadian First Nations Community. Becky Luk (PTLS) Tanya Petraszko, MD

Stem Cell Transplantation and the Canadian First Nations Community. Becky Luk (PTLS) Tanya Petraszko, MD Stem Cell Transplantation and the Canadian First Nations Community Becky Luk (PTLS) Tanya Petraszko, MD Why is there a need for stem cells? Our Story Why are we engaging the First Nations, Metis and Inuit

More information

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons LYMPHOMA BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons Normal development of lymphocytes Lymphocyte proliferation and differentiation:

More information

Coding for Hematology

Coding for Hematology Audio Seminar/Webinar April 2, 2009 Practical Tools for Seminar Learning Copyright 2009 American Health Information Management Association. All rights reserved. Disclaimer The American Health Information

More information

Leukemias and Lymphomas: A primer

Leukemias and Lymphomas: A primer Leukemias and Lymphomas: A primer Normal blood contains circulating white blood cells, red blood cells and platelets 700 red cells (oxygen) 1 white cell Neutrophils (60%) bacterial infection Lymphocytes

More information

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014 ABOUT BLOOD CANCERS Leukemia, Hodgkin lymphoma (HL), non-hodgkin lymphoma (NHL), myeloma, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs) are types of cancer that can affect the

More information

Why you should store your umbilical cord blood and cord tissue...

Why you should store your umbilical cord blood and cord tissue... Why you should store your umbilical cord blood and cord tissue... 2 Life is full of unique moments. Moments that will never pass your way again. Like the first time you hold your newborn baby in your arms.

More information

Discover the power of your newborn s cord blood.

Discover the power of your newborn s cord blood. Discover the power of your newborn s cord blood. What s so special about your newborn s cord blood? Your baby s umbilical cord blood is a valuable source of noncontroversial stem cells. Cord blood stem

More information

For your reference, this document is divided into the following parts: If you have any questions please do not hesitate to contact us.

For your reference, this document is divided into the following parts: If you have any questions please do not hesitate to contact us. Dear Parents, This is the Cells4Life Cord Blood collection, testing and cryopreservation agreement and it is a legal document. We request that you read it very carefully as it sets out the entire agreement

More information

Cord Blood Banking: an OB s Perspective

Cord Blood Banking: an OB s Perspective Cord Blood Banking: an OB s Perspective BY JORDAN H. PERLOW, MD Cord blood as a source of stem cells doesn t have the drawbacks of hard-to-match bone marrow or pose the ethical conundrum of embryonic stem

More information

Lymphoid Neoplasms. Sylvie Freeman Department of Clinical Immunology, University of Birmingham

Lymphoid Neoplasms. Sylvie Freeman Department of Clinical Immunology, University of Birmingham Lymphoid Neoplasms Sylvie Freeman Department of Clinical Immunology, University of Birmingham Incidence of Haematological Malignancies UK2001 (CRUK) Malignancy New Cases All Cancers 271,000 Leukaemia 6,760

More information

China Cord Blood Corporation (NYSE : CO) Corporate Presentation - December 2014

China Cord Blood Corporation (NYSE : CO) Corporate Presentation - December 2014 China Cord Blood Corporation (NYSE : CO) Corporate Presentation - December 2014 1 Disclaimers This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act

More information

Malignant neoplasms of ill-defined, secondary and unspecified sites (C76 C80)

Malignant neoplasms of ill-defined, secondary and unspecified sites (C76 C80) Malignant neoplasms of ill-defined, secondary and unspecified sites (C76 C80) C76 Malignant neoplasm of other and ill-defined sites Excludes: malignant neoplasm of: genitourinary tract NOS: female (C57.9)

More information

New Hampshire Childhood Cancer

New Hampshire Childhood Cancer Introduction: New Hampshire Childhood Cancer New Hampshire, Childhood Cancer, January 2009 Issue Brief Cancer in children is relatively uncommon, impacting fewer than twenty two of every 100,000 children

More information

About B Cell Lymphomas Groupmeeting Klipp/Spang, December 09 2002 Dennis Kostka Max-Planck-Institute for Molecular Genetics Computational Molecular Biology Berlin 1 Overview Short History of Lymphoma Classification

More information

information for payers and referrers

information for payers and referrers a d u lt s t e m c e l l t r a n s p l a n tat i o n p r o g r a m information for payers and referrers Spring 2014 For more information, visit www.dfbwcc.org/bmt. o u r expertise Since its founding in

More information

ICD-10 FREQUENTLY ASKED QUESTIONS

ICD-10 FREQUENTLY ASKED QUESTIONS ICD-10 FREQUENTLY ASKED QUESTIONS Q1. What is ICD-10? A1. ICD-10 is a diagnostic coding system implemented by the World Health Organization (WHO) in 1993 to replace ICD- 9. The system was developed by

More information

P R E S S K I T 2013 TABLE OF CONTENTS. About the European Group for Blood and Marrow Transplantation

P R E S S K I T 2013 TABLE OF CONTENTS. About the European Group for Blood and Marrow Transplantation TABLE OF CONTENTS About the European Group for Blood and Marrow Transplantation Haematopoietic Stem Cell Transplantation (HSCT): Key facts & figures EBMT Data - A foundation for cutting-edge research Clinical

More information

TM SM www. genecell.com

TM SM www. genecell.com TM SM www.genecell.com Why is umbilical cord blood so special? Umbilical cord blood is a rich source of stem cells, which may potentially help your baby and your family from numerous diseases. There are

More information

The Patient Access Network (PAN) Foundation Eligibility Diseases Targeted Contact Information

The Patient Access Network (PAN) Foundation Eligibility Diseases Targeted Contact Information The Patient Access Network (PAN) Foundation is an independent non-profit organization that provides assistance to underinsured patients for their out-of-pocket expenses through more than 40 disease-specific

More information

Non-Hodgkin s lymphoma. Univ. Prof. Dr. Werner Linkesch Univ. Klinik Graz

Non-Hodgkin s lymphoma. Univ. Prof. Dr. Werner Linkesch Univ. Klinik Graz Non-Hodgkin s lymphoma Univ. Prof. Dr. Werner Linkesch Univ. Klinik Graz NON-HODGKIN S LYMPHOMA (NHL) Approximately 1.5 million people worldwide are living with non-hodgkin s lymphoma (NHL), and it is

More information

Systemic Lupus Erythematosus

Systemic Lupus Erythematosus Harvard-MIT Division of Health Sciences and Technology HST.021: Musculoskeletal Pathophysiology, IAP 2006 Course Director: Dr. Dwight R. Robinson Systemic Lupus Erythematosus A multi-system autoimmune

More information

BCSLS Telehealth Stem Cell Transplantation. Our Story. Diseases treated with stem cell transplants. Why is there a need for stem cells?

BCSLS Telehealth Stem Cell Transplantation. Our Story. Diseases treated with stem cell transplants. Why is there a need for stem cells? BCSLS Telehealth Stem Cell Transplantation Becky Luk, Patient & Transplant Liaison Specialist Our Story Why is there a need for stem cells? What is OneMatch Stem Cell & Marrow Newtork s role in Stem Cell

More information

BCSLS Telehealth Stem Cell Transplantation. Becky Luk, Patient & Transplant Liaison Specialist

BCSLS Telehealth Stem Cell Transplantation. Becky Luk, Patient & Transplant Liaison Specialist BCSLS Telehealth Stem Cell Transplantation Becky Luk, Patient & Transplant Liaison Specialist Our Story Why is there a need for stem cells? What is OneMatch Stem Cell & Marrow Newtork s role in Stem Cell

More information

This module consists of four units which will provide the user a basic knowledge of cancer as a disease.

This module consists of four units which will provide the user a basic knowledge of cancer as a disease. Module 5: What is Cancer? This module consists of four units which will provide the user a basic knowledge of cancer as a disease. After completing this module, cancer abstractors will be able to: Define

More information

More transplant success.

More transplant success. More stem cells. More transplant success. ViaCord has the highest published transplant success rates. 2,9a FOR CURRENT Treatments * - All transplant recipients were conditioned with chemotherapy/radiation

More information

SEER SINQ s. Finalized March 2011

SEER SINQ s. Finalized March 2011 ized March 2011 : 20110067 First course treatment--heme & Lymphoid Neoplasms: Are the treatment guidelines in the "red book" still valid? See discussion. While I realize that the Hematopoietic Database

More information

Non Hodgkin Lymphoma:

Non Hodgkin Lymphoma: Non Hodgkin Lymphoma: Non Hodgkin Lymphoma, often referred to as NHL, is a cancer originating in the lymphocytes, a type of blood cell, which are integral to the body s immune system. Non Hodgkin Lymphoma

More information

FEHB Program Carrier Letter Health Maintenance Organizations

FEHB Program Carrier Letter Health Maintenance Organizations FEHB Program Carrier Letter Health Maintenance Organizations U.S. Office of Personnel Management Healthcare and Insurance Letter No. 2011-10(a) Date: May 4, 2011 Fee-for-service [ n/a] Experience-rated

More information

Stem cells of umbilical cord blood banking

Stem cells of umbilical cord blood banking Archives of Perinatal Medicine 21(2), 17-22, 2015 REVIEW PAPER Stem cells of umbilical cord blood banking MARTA KRUSZYŃSKA, GRZEGORZ KRUSZYŃSKI, GRZEGORZ H. BRĘBOROWICZ 1 Abstract Current understanding

More information

A Source of Hard- to- Find Pa3ents and Caregivers For Researchers. Peter Ziedins Peter.ziedins@mpiresearch.ca 514-426- 9295 www.rarepa;entvoice.

A Source of Hard- to- Find Pa3ents and Caregivers For Researchers. Peter Ziedins Peter.ziedins@mpiresearch.ca 514-426- 9295 www.rarepa;entvoice. A Source of Hard- to- Find Pa3ents and Caregivers For Researchers Peter Ziedins Peter.ziedins@mpiresearch.ca 514-426- 9295 www.rarepa;entvoice.com About RPV Rare Pa3ent Voice, LLC was formed to provide

More information

Local Coverage Article: Drugs and Biologicals - Chemotherapeutic Agents (A52701)

Local Coverage Article: Drugs and Biologicals - Chemotherapeutic Agents (A52701) Local Coverage Article: Drugs and Biologicals - Chemotherapeutic Agents (A52701) Contractor Information Contractor Name Cahaba Government Benefit Administrators, LLC Article Information General Information

More information

Technical University of Mombasa Faculty of Applied and Health Sciences

Technical University of Mombasa Faculty of Applied and Health Sciences Technical University of Mombasa Faculty of Applied and Health Sciences DEPARTMENT OF MEDICAL SCIENCES UNIVERSITY EXAMINATION FOR THE DEGREE OF BACHELOR OF MEDICAL LABORATORY SCIENCES BMLS 12S Mid AML 4321

More information

Ruling of the Bioethics Commission at the Federal Chancellery 19th May 2008. Report of the Bioethics Commission regarding Umbilical Cord Blood Banking

Ruling of the Bioethics Commission at the Federal Chancellery 19th May 2008. Report of the Bioethics Commission regarding Umbilical Cord Blood Banking BIOETHICS COMMISSION Ruling of the Bioethics Commission at the Federal Chancellery 19th May 2008 Report of the Bioethics Commission regarding Umbilical Cord Blood Banking Collecting Stem Cells from Umbilical

More information

Immunohistochemical classification of malignant lymphomas

Immunohistochemical classification of malignant lymphomas Immunohistochemical classification of malignant lymphomas Prof. Mogens Vyberg NordiQC Institute of Pathology Aalborg, Denmark Thanks to Jan Klos Important issues Distinction from non-hematopoietic neoplasms

More information

Challenging Diagnosis in Hematopathology

Challenging Diagnosis in Hematopathology Challenging Diagnosis in Hematopathology S. David Hudnall, M.D. Professor of Pathology & Laboratory Medicine Chief, Division of Hematopathology Yale University School of Medicine dhudnall@yale.edu Challenging

More information

BLOOD AND MARROW TRANSPLANT Notification Form (Day 100 report)

BLOOD AND MARROW TRANSPLANT Notification Form (Day 100 report) tification Form (Day 100 report) i. Centre Code: iii. Place of Transplant centre: Or Reporting centre name: ii. Date of this Report : iv. Name of Transplant centre: 1. APBMT Center #:. CIBMTR Center #:

More information

3 PART ONE: The Principles of Hematology 1 4 2 PART TWO: Erythrocytes 89 5

3 PART ONE: The Principles of Hematology 1 4 2 PART TWO: Erythrocytes 89 5 CONTENTS Preface iv PART ONE: The Principles of Hematology 1 1 Safety and Quality in the Hematology Laboratory................................. 1 An Overview of the Hematology Laboratory 1 The Study of

More information

Allogeneic Hematopoietic Stem-Cell Transplantation for Genetic Diseases and Acquired Anemias

Allogeneic Hematopoietic Stem-Cell Transplantation for Genetic Diseases and Acquired Anemias Allogeneic Hematopoietic Stem-Cell Transplantation for Genetic Diseases and Acquired Anemias Policy Number: 8.01.22 Last Review: 7/2016 Origination: 7/2002 Next Review: 7/2017 Policy Blue Cross and Blue

More information

frc Adult Stem Cell Treatments Nine Faces of Success FAMILY RESEARCH COUNCIL BE ENGAGED Policy Publication Releases: Help Us Get Others Engaged:

frc Adult Stem Cell Treatments Nine Faces of Success FAMILY RESEARCH COUNCIL BE ENGAGED Policy Publication Releases: Help Us Get Others Engaged: frc FAMILY RESEARCH COUNCIL Adult Stem Cell Treatments Nine Faces of Success BE ENGAGED Policy Publication Releases: Highlights new and notable publications from Family Research Council. It's a must for

More information

Non-Hodgkin Lymphoma

Non-Hodgkin Lymphoma Non-Hodgkin Lymphoma What is non-hodgkin lymphoma? Cancer starts when cells in the body begin to grow out of control. Cells in nearly any part of the body can become cancer, and can spread to other areas

More information

MODERN IMMUNOHISTOCHEMISTRY

MODERN IMMUNOHISTOCHEMISTRY MODERN IMMUNOHISTOCHEMISTRY Cambridge Illustrated Surgical Pathology Peiguo G. Chu City of Hope National Medical Center, Duarte, California Lawrence M. Weiss City of Hope National Medical Center, Duarte,

More information

Gateway Health SM Non-Formulary Prior Authorization Criteria Intravenous Immune Globulin (IVIG)

Gateway Health SM Non-Formulary Prior Authorization Criteria Intravenous Immune Globulin (IVIG) Gateway Health SM Non-Formulary Prior Authorization Criteria Intravenous Immune Globulin (IVIG) Coverage is provided in the following situations: PARP Approved 6/2015 Coverage is provided for Primary Immunodeficiency

More information

Stem Cell Transplantation

Stem Cell Transplantation Harmony Behavioral Health, Inc. Harmony Behavioral Health of Florida, Inc. Harmony Health Plan of Illinois, Inc. HealthEase of Florida, Inc. Ohana Health Plan, a plan offered by WellCare Health Insurance

More information

Tράπεζα Αίματος Ομφάλιου Λώρου Umbilical Cord Blood Bank

Tράπεζα Αίματος Ομφάλιου Λώρου Umbilical Cord Blood Bank Tράπεζα Αίματος Ομφάλιου Λώρου Umbilical Cord Blood Bank The first Stem cell bank in Europe Lifeline was established in the UK in 1994 and has been operating in Cyprus as a regional bank providing cord

More information

Immunohistochemistry of soft tissue tumors

Immunohistochemistry of soft tissue tumors Immunohistochemistry of soft tissue tumors Immunohistochemistry Major advances : antigen retrieval techniques (HIER) sensitive detection systems numerous antibodies of good quality Standardization : automated

More information

A Greater Hope for Cure as Singapore Cord Blood Bank Facilitates 100 th Unrelated Cord Blood Transplant

A Greater Hope for Cure as Singapore Cord Blood Bank Facilitates 100 th Unrelated Cord Blood Transplant PRESS RELEASE For Immediate Release A Greater Hope for Cure as Singapore Cord Blood Bank Facilitates 100 th Unrelated Cord Blood Transplant The non-profit public cord blood bank marks a major milestone

More information

Non-Hodgkin s lymphoma

Non-Hodgkin s lymphoma Non-Hodgkin s lymphoma Univ. Prof. Dr. Werner Linkesch Leiter der Klinischen Abteilung für Hämatologie LKH-Univ. Klinikum Graz Univ. Klinik für Innere Medizin NON-HODGKIN S LYMPHOMA (NHL) Approximately

More information

PT CordLife Indonesia Premium Cordblood Bank. PT CordLife Indonesia Premium Cordblood Bank

PT CordLife Indonesia Premium Cordblood Bank. PT CordLife Indonesia Premium Cordblood Bank Cordblood Stem Cells and The Role of Cordblood Bank in Supporting Stem Cells Research Presentation Overview Company profile Haematopoietic stem cells in cordblood What we can do to help 1 2 PT CordLife

More information

Leukemia to Leukodystrophy: Curative Role of Umbilical Cord Blood Transplantation

Leukemia to Leukodystrophy: Curative Role of Umbilical Cord Blood Transplantation Leukemia to Leukodystrophy: urative Role of Umbilical ord Blood Transplantation Vinod K. Prasad, MD, MRP (London) Pediatric Marrow and Stem ell Transplantation, Duke University Hematopoietic Stem ell Transplantation

More information

Non-Hodgkin Lymphoma Richard Orlowski, MD

Non-Hodgkin Lymphoma Richard Orlowski, MD Non-Hodgkin Lymphoma Richard Orlowski, MD The American Cancer Society (ACS) estimates that 69,740 Americans will be diagnosed with non-hodgkin lymphoma (NHL) in 2013. Excluding non-melanoma skin cancers,

More information

Malignant Lymphomas and Plasma Cell Myeloma

Malignant Lymphomas and Plasma Cell Myeloma Malignant Lymphomas and Plasma Cell Myeloma Dr. Bruce F. Burns Dept. of Pathology and Lab Medicine Overview definitions - lymphoma lymphoproliferative disorder plasma cell myeloma pathogenesis - translocations

More information

Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, 272-275 5-HT, see Serotonin

Index. F Factor VIII-related antigen, see VWF FactorXIIIa, for dermatofibroma, 272-275 5-HT, see Serotonin A Acantholytic squamous cell carcinoma vs epithelioid angiosarcoma, 56-57 Acinic cell carcinoma of pancreas, 76-77 vs ductal adenocarcinoma, 74-75 vs islet cell tumor, 78-81 Adenomatoid tumor vs hemangioma,

More information

Friend for Life Cancer Support Network Annual Report 2010. Facing cancer, with someone who s been there

Friend for Life Cancer Support Network Annual Report 2010. Facing cancer, with someone who s been there Friend for Life Cancer Support Network Annual Report 2010 Facing cancer, with someone who s been there This is wonderful support for those of us who are newly diagnosed with cancer. Our Mission To help

More information

DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT

DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT www.narayanahealth.org DEPARTMENT OF BONE MARROW AND STEM CELL TRANSPLANT About Narayana Health City Narayana Health, one of India's largest and the world's most economical healthcare service providers

More information

Cancer. 9p21.3 deletion. t(12;21) t(15;17)

Cancer. 9p21.3 deletion. t(12;21) t(15;17) CANCER FISH PROBES INDIVIDUAL AND PANEL S Acute Lymphoblastic Leukemia (ALL) ALL FISH Panel (includes all probes below) 8010 LSI MYB/CEP6 LSI p16 (CDKN2A) LSI BCR/ABL with ASS LSI ETV6 (TEL)/AML1 (RUNX1)

More information

Role of Transfusion Medicine Consultant in Peripheral Blood Stem Cell Transplant Program

Role of Transfusion Medicine Consultant in Peripheral Blood Stem Cell Transplant Program Role of Transfusion Medicine Consultant in Peripheral Blood Stem Cell Transplant Program Dr Anita Tendulkar MD(Path),DPB,DIT Associate Professor Transfusion Medicine Tata Memorial Hospital Advanced Centre

More information

Hodgkin and Non-Hodgkin Lymphoma Pre-HCT Data

Hodgkin and Non-Hodgkin Lymphoma Pre-HCT Data (Form 2018) This section of the CIBMTR Forms Instruction Manual is intended to be a resource for completing the Hodgkin and Non-Hodgkin Lymphoma Pre-HCT Data Form. E-mail comments regarding the content

More information

B-cell Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

B-cell Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma 2008 WHO Classification of Lymphoid Neoplasms: Small B-Cell Neoplasms Chronic lymphocytic leukemia/small lymphocytic lymphoma B-cell prolymphocytic leukemia Splenic marginal zone B-cell lymphoma Hairy

More information

WBMT Global Survey. Helen Baldomero Cape Town November 2014. Worldwide Network for Blood and Marrow Transplantation

WBMT Global Survey. Helen Baldomero Cape Town November 2014. Worldwide Network for Blood and Marrow Transplantation WBMT Global Survey Helen Baldomero Cape Town November 214 NGO in official relations with World Health Organization Leukemias LPD Solid tumors Non - Malignant disorders NGO in official relations with World

More information

Contents. 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1. 2. Head, Neck, Orbit and Salivary Glands... 12

Contents. 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1. 2. Head, Neck, Orbit and Salivary Glands... 12 Contents 1. Introduction and Approach to Fine Needle Aspiration Cytology... 1 Complications 1 Fine Needle Aspiration Technique 1 Evaluation of FNAC Smear 4 Cell Morphology 4 Nucleus 4 Cytoplasm 6 Background

More information

Locoregional & advanced esophagus or esophagogastric junction cancer

Locoregional & advanced esophagus or esophagogastric junction cancer Eloxatin (oxaliplatin) Prior Authorization Request (For Maryland Only) Send completed form to: Case Review Unit CVS/caremark Specialty Programs Fax: 866-249-6155 CVS/caremark administers the prescription

More information

# Circuits relevant to cancer, related to known TFs.

# Circuits relevant to cancer, related to known TFs. # Circuits relevant to cancer, related to known TFs. # Final dataset of circuits where at least one gene has been annotated as relevant to cancer. # Circuits correspond to blocks separated by a symbol.

More information

Discover the power of your newborn s cord blood.

Discover the power of your newborn s cord blood. Discover the power of your newborn s cord blood. What s so special about your newborn s cord blood? Your baby s umbilical cord blood is a valuable source of Cord Blood Overview noncontroversial stem cells.

More information

Stem Cell Banking. Umbilical Cord. The Leading Cell Bank www.stemology.co.uk. Protect your family s future

Stem Cell Banking. Umbilical Cord. The Leading Cell Bank www.stemology.co.uk. Protect your family s future Protect your family s future The Leading Cell Bank www.stemology.co.uk Stem Cell Banking Umbilical Cord For women in their 1st, 2nd or 3rd Trimester of Pregnancy Introduction to Stemology Imagine you

More information

The Leading Cell Bank www.stemology.co.uk. Protect Your Family s Future. Stem Cell Banking. Umbilical Cord. Only for Expecting Parents

The Leading Cell Bank www.stemology.co.uk. Protect Your Family s Future. Stem Cell Banking. Umbilical Cord. Only for Expecting Parents Protect Your Family s Future The Leading Cell Bank www.stemology.co.uk Stem Cell Banking Umbilical Cord Only for Expecting Parents Introduction to Stemology Imagine you could replace any cells in your

More information

Cytokines: Physiology and Clinical Relevance Pranay D. Khare, Ph.D. and Meenakshi Khare, Ph.D.

Cytokines: Physiology and Clinical Relevance Pranay D. Khare, Ph.D. and Meenakshi Khare, Ph.D. Cytokines: Physiology and Clinical Relevance Pranay D. Khare, Ph.D. and Meenakshi Khare, Ph.D. A shift in medicine is taking place. It is characterized by the emergence of neuroendoimmunology (NEI), a

More information

Understanding Non-Hodgkin Lymphoma

Understanding Non-Hodgkin Lymphoma Understanding Non-Hodgkin Lymphoma A Guide For Patients, Survivors, and Loved Ones Fourth Edition This guide is an educational resource compiled by the Lymphoma Research Foundation (LRF) that provides

More information

Phone: +44 20 8123 2220 Fax: +44 207 900 3970 office@marketpublishers.com http://marketpublishers.com

Phone: +44 20 8123 2220 Fax: +44 207 900 3970 office@marketpublishers.com http://marketpublishers.com Global Stem Cell Umbilical Cord Blood (UCB) Market (Storage Service, Therapeutics, Application, Geography) - Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012-2020

More information

MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS

MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS MOH Policy for dispensing NEOPLASTIC DISEASES DRUGS All prescriptions for antineoplastic drugs must be accompanied by the MOH special form. All the attachments mentioned on this form shall be submitted

More information

Rev. Tadeusz Pacholczyk

Rev. Tadeusz Pacholczyk STEM CELL RESEARCH AND CLONING Rev. Tadeusz Pacholczyk Certain misconceptions surrounding stem cell research and cloning have come to be routinely presented in the mass media. These are the ten great media

More information

GRANIX (tbo-filgrastim)

GRANIX (tbo-filgrastim) RATIONALE FOR INCLUSION IN PA PROGRAM Background Neutropenia is a hematological disorder characterized by an abnormally low number of neutrophils. A person with severe neutropenia has an absolute neutrophil

More information

RITUXAN (rituximab) RATIONALE FOR INCLUSION IN PA PROGRAM

RITUXAN (rituximab) RATIONALE FOR INCLUSION IN PA PROGRAM RATIONALE FOR INCLUSION IN PA PROGRAM Background Rituxan is a monoclonal antibody that is manufactured through biotechnology methods rather than by the human body s own immune system. The drug works by

More information

Medical Policy Manual. Topic: Allogeneic Hematopoietic Stem-Cell Transplantation for Genetic Diseases and Acquired Anemias. Date of Origin: May 2010

Medical Policy Manual. Topic: Allogeneic Hematopoietic Stem-Cell Transplantation for Genetic Diseases and Acquired Anemias. Date of Origin: May 2010 Medical Policy Manual Topic: Allogeneic Hematopoietic Stem-Cell Transplantation for Genetic Diseases and Acquired Anemias Date of Origin: May 2010 Section: Transplant Last Reviewed Date: February 2015

More information

Non-Hodgkin Lymphoma in Queensland An Overview 2012

Non-Hodgkin Lymphoma in Queensland An Overview 2012 Non-Hodgkin Lymphoma in Queensland An Overview 2012 Acknowledgements The authors acknowledge and appreciate the work of Queensland Health staff that contribute to and participate in the maintenance of

More information

Part II: NCCN Practice Guidelines Narrative Summary PET and PET/CT

Part II: NCCN Practice Guidelines Narrative Summary PET and PET/CT Part II: NCCN Practice Guidelines Narrative Summary PET and PET/CT NCCN guidelines were reviewed on 3/25/2013 for utilization of 18 F-fluorodeoxyglucose (FDG) PET and PET/CT (available at: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp).

More information

Why hematopoietic stem cell transplantation and for whom?

Why hematopoietic stem cell transplantation and for whom? Why hematopoietic stem cell transplantation and for whom? A.J. Cant, C. Craddock and R. Skinner Introduction Transplantation of allogeneic and autologous hematopoietic stem cells has become an increasingly

More information

Interesting Case Review. Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA

Interesting Case Review. Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA Interesting Case Review Renuka Agrawal, MD Dept. of Pathology City of Hope National Medical Center Duarte, CA History 63 y/o male with h/o CLL for 10 years Presents with worsening renal function and hypercalcemia

More information